A Prospective, Post-Market, Multicenter Trial (CHEETAH) Suggested TearCare® System as a Safe and Effective Blink-Assisted Eyelid Device for the Treatment of Dry Eye Disease

por Karpecki P, Wirta D, Osmanovic S, Dhamdhere K
Publicado 2020

A Post-Acute Ocular Tolerability Comparison of Topical Reproxalap 0.25% and Lifitegrast 5% in Patients with Dry Eye Disease

por McMullin D, Clark D, Cavanagh B, Karpecki P, Brady TC
Publicado 2021

Managing Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current Therapies

por Shen Lee B, Kabat AG, Bacharach J, Karpecki P, Luchs J
Publicado 2020

Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca

por Sheppard J, Bergmann M, Schechter BA, Luchs J, Ogundele A, Karpecki P
Publicado 2021

Evaluation of a new artificial tear formulation for the management of tear film stability and visual function in patients with dry eye

por Torkildsen G, Brujic M, Cooper MS, Karpecki P, Majmudar P, Trattler W, Reis M, Ciolino JB
Publicado 2017